Streck Paul
- SEC CIK
- 0001708063
In the past year, 1 open-market sale filing worth $11.7K and no purchases.
Current role at each company
- PEPG PepGen Inc.EVP, Head of R&Das of Mar 6, 2026
- ALBO Albireo Pharma, Inc.Chief Medical Officeras of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $11.7K
- 1 filing
- Net
- −$11.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Streck Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PEPG PepGen Inc.
EVP, Head of R&D2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Streck PaulEVP, Head of R&D | SSale | −1.88K | $6.23 | −$11.7K | −2.4%76.2K after | 2 lots |
| Jun 2, 2025 (view filing) | May 30 | 3 days | Streck PaulEVP, Head of R&D | PPurchase | +8.38K | $1.24 | +$10.4K | +43.1%27.8K after |